The drug Engensis looks extremely interesting. It is a Korean company called Helixmith. The drug is finishing up Phase III trials which is the last phase of study. Hopefully they will submit an NDA ( New Drug Application) to the FDA this year. It is an injection. This could be a real game changer if it makes it through.